Recognition of biomarker identified high-risk patients in the acute medically ill venous thromboembolism prevention with extended duration betrixaban study resulting in a protocol amendment.

Published

Journal Article (Letter)

Full Text

Duke Authors

Cited Authors

  • Cohen, AT; Harrington, R; Goldhaber, SZ; Hull, R; Gibson, CM; Hernandez, AF; Gold, A

Published Date

  • January 2015

Published In

Volume / Issue

  • 169 / 1

Start / End Page

  • 186 - 187

PubMed ID

  • 25497265

Pubmed Central ID

  • 25497265

Electronic International Standard Serial Number (EISSN)

  • 1097-6744

Digital Object Identifier (DOI)

  • 10.1016/j.ahj.2014.09.004

Language

  • eng

Conference Location

  • United States